Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection ...

The study included adults ≥18 years old who received high-dose IV methotrexate and developed methotrexate-associated AKI, defined as a ≥1.5-fold increase in serum creatinine within 4 days ...

No previous study has investigated whether glucarpidase improves important clinical outcomes in patients with methotrexate-associated acute kidney injury (AKI).

Injectable drugs such as methotrexate and biologics may help ... itching, or a rash at the injection site urinary tract infection Two types of biologic drugs are Food and Drug Administration ...

Infliximab Remicaid® Chimeric monoclonal antibody iv. infusion, 3 mg/kg at 0, 2 and 6 weeks followed by maintenance every 4–8 weeks Golimumab Simponi® Human monoclonal antibody sc. injection ...

Ketorolac tromethamine 15mg/mL, 30mg/mL; for IM or IV inj; contains alcohol ... May increase serum lithium, methotrexate levels. ACEIs, diuretics increase renal toxicity risk.

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...